Bruce Binkowitz Email

VP Biometrics . Arcutis Biotherapeutics

Current Roles

Employees:
316
Revenue:
$27.6M
About
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our teamᅢᄁ¬ツᆲ¬トᄁs unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches. Arcutis' combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.
Arcutis Biotherapeutics Address
3027 Townsgate Road
Westlake Village, CA
USA
Arcutis Biotherapeutics Email

Past Companies

Arcutis Biotherapeutics, Inc.Vice President of Biometrics
Shionogi Inc.Vice President, Biometrics
MerckExecutive Director and Late Development Statistics Research Group 2 Leader

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.